MOH
Income statement / Annual
Last year (2023), Molina Healthcare, Inc.'s total revenue was $34.07 B,
an increase of 6.56% from the previous year.
In 2023, Molina Healthcare, Inc.'s net income was $1.09 B.
See Molina Healthcare, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$34.07 B
|
$31.97 B
|
$27.77 B
|
$19.42 B
|
$16.83 B
|
$18.89 B
|
$19.88 B
|
$17.71 B
|
$14.07 B
|
$9.67 B
|
| Cost of Revenue |
$29.74 B |
$28.05 B |
$24.49 B |
$16.75 B |
$14.39 B |
$16.27 B |
$18.00 B |
$15.94 B |
$12.43 B |
$8.62 B |
| Gross Profit |
$4.33 B |
$3.93 B |
$3.28 B |
$2.68 B |
$2.44 B |
$2.62 B |
$1.88 B |
$1.77 B |
$1.64 B |
$1.05 B |
| Gross Profit Ratio |
0.13 |
0.12 |
0.12 |
0.14 |
0.14 |
0.14 |
0.09 |
0.1 |
0.12 |
0.11 |
| Research and Development
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative
Expenses |
$2.46 B
|
$2.31 B
|
$2.07 B
|
$1.48 B
|
$1.30 B
|
$1.33 B
|
$1.59 B
|
$1.39 B
|
$1.15 B
|
$764.69 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$2.46 B
|
$2.31 B
|
$2.07 B
|
$1.48 B
|
$1.30 B
|
$1.33 B
|
$1.59 B
|
$1.39 B
|
$1.15 B
|
$764.69 M
|
| Other Expenses |
$299.00 M |
$234.00 M |
$192.00 M |
$119.00 M |
$89.00 M |
-$17.00 M |
$61.00 M |
$139.00 M |
$2.00 M |
-$802,000.00 |
| Operating Expenses |
$2.76 B |
$2.55 B |
$2.26 B |
$1.60 B |
$1.39 B |
$1.43 B |
$1.73 B |
$1.53 B |
$1.25 B |
$857.61 M |
| Cost And Expenses |
$32.50 B |
$30.59 B |
$26.75 B |
$18.35 B |
$15.78 B |
$17.70 B |
$19.73 B |
$17.47 B |
$13.69 B |
$9.47 B |
| Interest Income |
$0.00 |
$110.00 M |
$120.00 M |
$102.00 M |
$87.00 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Interest Expense |
$109.00 M |
$110.00 M |
$120.00 M |
$102.00 M |
$87.00 M |
$115.00 M |
$118.00 M |
$101.00 M |
$67.00 M |
$56.81 M |
| Depreciation &
Amortization |
$171.00 M
|
$176.00 M
|
$131.00 M
|
$88.00 M
|
$89.00 M
|
$127.00 M
|
$178.00 M
|
$182.00 M
|
$126.00 M
|
$134.40 M
|
| EBITDA |
$1.74 B
|
$1.35 B
|
$1.13 B
|
$1.15 B
|
$1.15 B
|
$1.24 B
|
-$316.00 M
|
$488.00 M
|
$514.00 M
|
$332.70 M
|
| EBITDA Ratio |
0.05 |
0.05 |
0.04 |
0.06 |
0.07 |
0.07 |
0.02 |
0.02 |
0.04 |
0.03 |
| Operating Income Ratio
|
0.05
|
0.04
|
0.04
|
0.06
|
0.06
|
0.06
|
-0.03
|
0.01
|
0.03
|
0.02
|
| Total Other
Income/Expenses Net |
-$109.00 M
|
-$110.00 M
|
-$145.00 M
|
-$117.00 M
|
-$72.00 M
|
-$132.00 M
|
-$57.00 M
|
-$101.00 M
|
-$65.00 M
|
-$58.00 M
|
| Income Before Tax |
$1.46 B |
$1.06 B |
$875.00 M |
$961.00 M |
$972.00 M |
$999.00 M |
-$612.00 M |
$137.00 M |
$322.00 M |
$135.30 M |
| Income Before Tax Ratio
|
0.04
|
0.03
|
0.03
|
0.05
|
0.06
|
0.05
|
-0.03
|
0.01
|
0.02
|
0.01
|
| Income Tax Expense |
$373.00 M |
$271.00 M |
$216.00 M |
$288.00 M |
$235.00 M |
$292.00 M |
-$100.00 M |
$129.00 M |
$179.00 M |
$72.73 M |
| Net Income |
$1.09 B |
$792.00 M |
$659.00 M |
$673.00 M |
$737.00 M |
$707.00 M |
-$512.00 M |
$8.00 M |
$143.00 M |
$62.22 M |
| Net Income Ratio |
0.03 |
0.02 |
0.02 |
0.03 |
0.04 |
0.04 |
-0.03 |
0 |
0.01 |
0.01 |
| EPS |
18.71 |
13.7 |
11.4 |
11.41 |
11.85 |
10.61 |
-9.14 |
0.93 |
2.75 |
1.33 |
| EPS Diluted |
18.78 |
13.54 |
11.25 |
11.24 |
11.48 |
10.55 |
-9.14 |
0.92 |
2.58 |
1.29 |
| Weighted Average Shares
Out |
$58.30 M
|
$57.80 M
|
$57.80 M
|
$59.00 M
|
$62.20 M
|
$66.64 M
|
$56.00 M
|
$55.00 M
|
$52.00 M
|
$47.00 M
|
| Weighted Average Shares
Out Diluted |
$58.10 M
|
$58.50 M
|
$58.60 M
|
$59.90 M
|
$64.20 M
|
$67.00 M
|
$56.00 M
|
$56.00 M
|
$56.00 M
|
$48.00 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
